Choline acetyltransferase 2384G>A polymorphism and the risk of Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 26, Issue 1, 2012, Pages 81-87

  Lee, Jung Jae ^a   Jo, Sangmee Ahn ^b   Park, Joon Hyuk ^d   Lee, Seok Bum ^c   Jo, Inho ^e   Kim, Do Kwan ^f   Huh, Yoonseok ⁱ   Youn, Jong Chul ^j   Jhoo, Jin Hyeong ^k   Park, Koung Un ⁱ   Park, Sung Sup ^g   Lee, Dong Young ^g,h   Woo, Jong Inn ^g,h   Kim, Ki Woong ^h,i  

^a Kyungpook National University Hospital   (South Korea)

^b Dankook University   (South Korea)

^c Dankook University College of Medicine   (South Korea)

^d Jeju National University   (South Korea)

^e Ewha Womans University   (South Korea)

^f Sungkyunkwan University   (South Korea)

^g Seoul National University Hospital   (South Korea)

^h Seoul National University   (South Korea)

ⁱ Seoul National University Bundang Hospital   (South Korea)

^j Kyunggi Provincial Hospital for Elderly   (South Korea)

^k Kangwon National University College of Medicine   (South Korea)

more..

Author keywords

Alzheimer disease (AD); apolipoprotein E; choline acetyltransferase; gene gene interaction; polymorphism

Indexed keywords

APOLIPOPROTEIN E4; CHOLINE ACETYLTRANSFERASE;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME POLYMORPHISM; FEMALE; GENE INTERACTION; GENOTYPE; HETEROZYGOTE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIFACTOR DIMENSIONALITY REDUCTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLINE O-ACETYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; RISK FACTORS;

EID: 84857782995     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31821cbcaf     Document Type: Article

References (37)

1. Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 1976;2:1403. (Pubitemid 8004505)
2. Perry EK, Perry RH, Blessed G, et al. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet. 1977;1:189. (Pubitemid 8020501)
3. Perry EK, Tomlinson BE, Blessed G, et al. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J. 1978;2:1457-1459. (Pubitemid 9061468)
4. Davies P. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res. 1979;171:319-327. (Pubitemid 10246672)
5. Beach TG, Kuo YM, Spiegel K, et al. The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease. J Neuropathol Exp Neurol. 2000; 59:308-313. (Pubitemid 30183698)
6. Wilcock GK, Esiri MM, Bowen DM, et al. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci. 1982;57:407-417. (Pubitemid 13212275)
7. Bierer LM, Haroutunian V, Gabriel S, et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem. 1995;64: 749-760.
8. DeKosky ST, Ikonomovic MD, Styren SD, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 2002;51:145-155. (Pubitemid 34111436)
9. Kozak M. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J. 1997;16:2482-2492. (Pubitemid 27260380)
10. Bertram L, Blacker D, Mullin K, et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 2000;290:2302-2303. (Pubitemid 32041570)
11. Myers A, Holmans P, Marshall H, et al. Susceptibility locus for Alzheimer's disease on chromosome 10. Science. 2000;290: 2304-2305. (Pubitemid 32041572)
12. Kim KW, Suh YJ, Park WY, et al. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with apolipoprotein E epsilon4. Neurosci Lett. 2004;366:182-186.
13. Jo SA, Ahn K, Kim JH, et al. ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G>A and 1882G>A) with Alzheimer's disease. Clin Chim Acta. 2006;368:179-182. (Pubitemid 43776017)
14. Harold D, Peirce T, Moskvina V, et al. Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Hum Genet. 2003;113:258-267. (Pubitemid 36992285)
15. Schwarz S, Eisele T, Diehl J, et al. Lack of association between a single nucleotide polymorphism within the choline acetyltransferase gene and patients with Alzheimer's disease. Neurosci Lett. 2003;343:167-170. (Pubitemid 38365977)
16. Cook LJ, Ho LW, Wang L, et al. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. Am J Med Genet B Neuropsychiatr Genet. 2005;132:5-8. (Pubitemid 40066186)
17. Ozturk A, DeKosky ST, Kamboh MI. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease. Neurobiol Aging. 2006;27: 1440-1444. (Pubitemid 44279895)
18. Tang M, Rao D, Ma C, et al. Evaluation of choline acetyltransferase gene polymorphism (2384 G/A) in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord. 2008;26:9-14.
19. Grunblatt E, Zehetmayer S, Bartl J, et al. Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study. J Psychiatr Res. 2009;43:298-308.
20. Moore JH, Williams SM. Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis. Bioessays. 2005;27:637-646. (Pubitemid 40896095)
21. Cohen EL, Wurtman RJ. Brain acetylcholine: increase after systemic choline administration. Life Sci. 1975;16: 1095-1102.
22. Haubrich DR, Chippendale TJ. Regulation of acetylcholine synthesis in nervous tissue. Life Sci. 1977;20:1465-1478. (Pubitemid 8118351)
23. Beffert U, Poirier J. Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann N Y Acad Sci. 1996;777:166-174. (Pubitemid 26149184)
24. Kim KW, Jhoo JH, Lee JH, et al. The domain-specific, stagelimited impact of the apolipoprotein E epsilon-4 allele on cognitive functions in Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;13:125-129. (Pubitemid 34224932)
25. Lou XY, Chen GB, Yan L, et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet. 2007;80:1125-1137. (Pubitemid 47579348)
26. Association AP. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association, 1994.
27. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 1984;34:939-944. (Pubitemid 14076461)
28. Park HD, Park KU, Kim KW, et al. Real-time multiplex PCR assay for genotyping of three apolipoprotein E alleles and two choline acetyltransferase alleles with three hybridization probes. Clin Chem Lab Med. 2007;45:346-350. (Pubitemid 46480907)
29. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69:138-147. (Pubitemid 32614026)
30. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003;19:376-382. (Pubitemid 36284937)
31. Wu LS, Hsieh CH, Pei D, et al. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARgamma and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant. 2009;24:3360-3366.
32. Mubumbila V, Sutter A, Ptok U, et al. Identification of a single nucleotide polymorphism in the choline acetyltransferase gene associated with Alzheimer's disease. Neurosci Lett. 2002; 333:9-12. (Pubitemid 35223590)
33. Baskin DS, Browning JL, Pirozzolo FJ, et al. Brain choline acetyltransferase and mental function in Alzheimer disease. Arch Neurol. 1999;56:1121-1123. (Pubitemid 29426799)
34. Kim JM, Shin IS, Yoon JS. Apolipoprotein E among Korean Alzheimer's disease patients in community-dwelling and hospitalized elderly samples. Dement Geriatr Cogn Disord. 2002;13:119-124.
35. Piccardi M, Congiu D, Squassina A, et al. Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample. Am J Med Genet B Neuropsychiatr Genet. 2007;144:895-899. (Pubitemid 47547990)
36. Harold D, Macgregor S, Patterson CE, et al. A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease. Pharmacogenet Genomics. 2006;16:75-77. (Pubitemid 43145675)
37. Berrington de Gonzalez A, Cox DR. Additive and multiplicative models for the joint effect of two risk factors. Biostatistics. 2005;6:1-9. (Pubitemid 41240365)